Diabetologie und Stoffwechsel 2018; 13(S 01): S19
DOI: 10.1055/s-0038-1641809
DOI: 10.1055/s-0038-1641809
Poster
Typ-2-Diabetes – Pathophysiologie I
TGFß regulates metabolism of human skeletal muscle cells by miRNAs
Authors
-
S Höckele
1 Helmholtz Zentrum München, Institute of Experimental Genetics, Neuherberg, Germany2 German Center for Diabetes Research (DZD), Neuherberg, Germany -
P Huypens
1 Helmholtz Zentrum München, Institute of Experimental Genetics, Neuherberg, Germany -
C Hoffmann
3 University Hospital Tübingen, Division of Endocrinology, Diabetology, Angiology, Nephrology, Pathobiochemistry and Clinical Chemistry, Department of Internal Medicine IV, Tübingen, Germany -
T Jeske
4 Helmholtz Zentrum München, Institute of Bioinformatics and Systems Biology, Neuherberg, Germany5 Dr. Hauner Children's Hospital, Ludwig-Maximilians-Universität München, Department of Pediatrics, München, Germany -
M Hastreiter
6 Helmholtz Zentrum München, Institute of Computational Biology, Neuherberg, Germany7 Technische Universität München, Lehrstuhl für Genomorientierte Bioinformatik, Freising, Germany -
A Böhm
2 German Center for Diabetes Research (DZD), Neuherberg, Germany3 University Hospital Tübingen, Division of Endocrinology, Diabetology, Angiology, Nephrology, Pathobiochemistry and Clinical Chemistry, Department of Internal Medicine IV, Tübingen, Germany8 University of Tübingen, Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Zentrum München, Tübingen, Germany -
J Beckers
1 Helmholtz Zentrum München, Institute of Experimental Genetics, Neuherberg, Germany2 German Center for Diabetes Research (DZD), Neuherberg, Germany9 Technische Universität München, Institute of Experimental Genetics, Freising, Germany -
HU Häring
2 German Center for Diabetes Research (DZD), Neuherberg, Germany3 University Hospital Tübingen, Division of Endocrinology, Diabetology, Angiology, Nephrology, Pathobiochemistry and Clinical Chemistry, Department of Internal Medicine IV, Tübingen, Germany8 University of Tübingen, Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Zentrum München, Tübingen, Germany -
M Hrabe de Angelis
1 Helmholtz Zentrum München, Institute of Experimental Genetics, Neuherberg, Germany2 German Center for Diabetes Research (DZD), Neuherberg, Germany9 Technische Universität München, Institute of Experimental Genetics, Freising, Germany -
C Weigert
2 German Center for Diabetes Research (DZD), Neuherberg, Germany3 University Hospital Tübingen, Division of Endocrinology, Diabetology, Angiology, Nephrology, Pathobiochemistry and Clinical Chemistry, Department of Internal Medicine IV, Tübingen, Germany8 University of Tübingen, Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Zentrum München, Tübingen, Germany

